Lack of DNA-dependent protein kinase (DNA-PK) activity confers radiosensitivity and defective DNA double-strand break repair. Nine human malignant glioma cell lines were studied to determine whether differences in DNA-PK activity reflect differences in inherent radiosensitivity or are predictive of tumor treatment response. DNA-PK activity was present in all cell extracts, as were the DNA-PK proteins, DNA-PK catalytic subunit, Ku p70, and Ku p80. No correlation was found between the levels of DNA-PK activity and inherent radiosensitivity or in the tumor treatment response. These preliminary results suggest that variation in DNA-PK activity may not be a determinant of clinical response in malignant glioma.


This work was supported by awards from the National Cancer Institute of Canada with funds provided by the Canadian Cancer Society, the Natural Sciences and Engineering Research Council (NSERC) (Canada), and the Alberta Cancer Board. S. P. L-M. is the recipient of an NSERC Women's Faculty Award.

This content is only available via PDF.